1. Home
  2. WOR vs NEO Comparison

WOR vs NEO Comparison

Compare WOR & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WOR
  • NEO
  • Stock Information
  • Founded
  • WOR 1955
  • NEO 2001
  • Country
  • WOR United States
  • NEO United States
  • Employees
  • WOR N/A
  • NEO N/A
  • Industry
  • WOR Aerospace
  • NEO Precision Instruments
  • Sector
  • WOR Consumer Discretionary
  • NEO Health Care
  • Exchange
  • WOR Nasdaq
  • NEO Nasdaq
  • Market Cap
  • WOR 2.1B
  • NEO 1.2B
  • IPO Year
  • WOR N/A
  • NEO 1999
  • Fundamental
  • Price
  • WOR $41.66
  • NEO $10.88
  • Analyst Decision
  • WOR Hold
  • NEO Strong Buy
  • Analyst Count
  • WOR 3
  • NEO 10
  • Target Price
  • WOR $49.00
  • NEO $19.78
  • AVG Volume (30 Days)
  • WOR 315.7K
  • NEO 1.4M
  • Earning Date
  • WOR 03-25-2025
  • NEO 04-29-2025
  • Dividend Yield
  • WOR 1.65%
  • NEO N/A
  • EPS Growth
  • WOR N/A
  • NEO N/A
  • EPS
  • WOR 0.85
  • NEO N/A
  • Revenue
  • WOR $1,166,910,000.00
  • NEO $660,566,000.00
  • Revenue This Year
  • WOR N/A
  • NEO $12.89
  • Revenue Next Year
  • WOR $2.83
  • NEO $11.36
  • P/E Ratio
  • WOR $48.71
  • NEO N/A
  • Revenue Growth
  • WOR N/A
  • NEO 11.65
  • 52 Week Low
  • WOR $37.88
  • NEO $8.98
  • 52 Week High
  • WOR $69.96
  • NEO $19.11
  • Technical
  • Relative Strength Index (RSI)
  • WOR 49.77
  • NEO 44.85
  • Support Level
  • WOR $39.28
  • NEO $8.98
  • Resistance Level
  • WOR $42.45
  • NEO $10.66
  • Average True Range (ATR)
  • WOR 1.29
  • NEO 0.85
  • MACD
  • WOR -0.12
  • NEO 0.06
  • Stochastic Oscillator
  • WOR 47.50
  • NEO 51.49

About WOR Worthington Enterprises Inc.

Worthington Enterprises Inc is a designer and manufacturer of products sold to consumers, through retail channels, in the tools, outdoor living and celebrations market categories as well as a wide array of specialized building products that serve customers in the residential and non-residential construction markets, including ceiling suspension systems and light gauge metal framing products, as well as wholly-owned and consolidated operations that produce pressurized containment solutions for heating, cooking and cooling applications, among others. It operates under two reportable operating segments: Consumer Products and Building Products. It derives majority of the revenue from Building Products segment.

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

Share on Social Networks: